论文部分内容阅读
据中国中药协会中药材信息中心的6月份监测报告,在监测的561个中药材品种中,有158个品种价格同比升高,占总量约28%;降价品种367个,占总量约66%;平价品种36个,占总量约6%。在降价的367个品种中,二级进口西红花(藏红花)每千克跌幅达到3500元,而湖北产的家种统货白前的降幅则达到了90%以上。云南产的三七价格依旧坚挺,同比涨幅均在300元/千克以上,但环比出现小幅下调。前两年,由于中药材市场交易活跃,部分品种受天气影响产量下降,加上各地商家囤积,中药材价格量价齐升。连续两年的高效益带动了药农、农商的
According to the monitoring report of the Chinese Medicinal Materials Information Center of China Association of Chinese Materia Medica in June, of the 561 Chinese herbal medicines monitored, 158 varieties rose in price year-on-year, accounting for about 28% of the total; 367 varieties with a price reduction of about 66 %; Parity varieties 36, accounting for about 6% of the total. Among the 367 varieties that have been reduced in price, the imports of saffron (saffron) at the secondary level have dropped by 3,500 yuan per kg, while that of Hubei-based pre-plantation products has dropped by more than 90%. Yunnan Marchberry prices are still strong, an increase of more than 300 yuan / kg, but slightly lower than the chain. The first two years, due to the active trading market of Chinese herbal medicines, some varieties affected by the weather, the decline in production, coupled with the accumulation of businesses around the country, Chinese medicine prices volume and price go up. Two years of high efficiency led the farmers, farmers